Skip to main content

Table 1 Total proteins detected in LC-MS of serum and tissue purified histories of normal and tumour samples

From: A novel method for isolation of histones from serum and its implications in therapeutics and prognosis of solid tumours

Proteins Tissue normal Tissue tumour Serum normal Serum tumour
Histones H2A type 1 (91.5%)
H2A type 2-A (91.5%)
H2A type 1-C (91.5%)
H2A type 1-F (86.1%)
H2B type 1E (91.5%)
H2B type 1C (91.5%)
H3.1 (99.2%)
H4 (59.2%)
H2A type 2-A (98.4%)
H2A type 1-C (98.4%)
H2B type 1E (98%)
H3.1 (99.2%)
H4 (98.4%)
H2A type 2-A (81.5%)
H2A type 1 (74.62%)
H2A type 1-C (50%)
H3.1 (59.2%)
H2B type 1E (57%)
H4 (60%)
H2A type 2-A (46.9%)
H2A type 1-C (33%)
H2A type 1-F (38.4%)
H2A type 1-E (30%)
H2A type 1 (33%)
H2A type 4 (33%)
H2B type 1E (57%)
H2B type 1C (35%)
H3.1 (40.7%)
H4 (47%)
Non-histones Prelamin A/C (26%)
KDM5D (274%)
ESF1 (30.6%)
ESF1 homolog (23.9%)
Acid-sensing ion channel 5 (12.9%)
Prelamin A/C (62.4%)
KDM5D (30.32%)
EIF2S3Y (29.8%)
ESF1 homolog (41%)
Acid-sensing ion channel (17.9%)
Ribonuclease UK114
Fibrinogen beta chain (65.75%)
Fibrinogen alpha chain (56.91%)
Isoform 2 of Fibrinogen alpha (69.45%)
Isoform 2 of Fibrinogen beta chain (70.96%)
Translation initiation factor elf-2B (46.1%)
Fertuin-B (47.6%)
Putative pheromone receptor (18.7%)
Fibrinogen beta chain (65.3%)
Fibrinogen alpha chain (43.3%)
Isoform 2 of Fibrinogen beta chain (67.4%)
Isoform 2 of Fibrinogen alpha chain (59.6%)
Matrix estracellular phosphoglycoprotein (60%)
Potassium voltage-gated channel subfamily C member 2 (30.8%)
ESF1 homolog (57.9%)
Alkaline phosphatase (57%)
Indoleamine 2.3-dioxygenase 1 (37.8%)
Aldehyde oxidase 2 (29.6%)
Astrocytic phosphoprotein (69.9%)
Transcription factor YY2 (32.9%)
Cannabinoid receptor 1 (11.1%)
Putative pheromone receptor (19.1%)